Skip to content
Sign in
Artwork for Tomorrow Unveiled: Your Weekly Tech Briefing
Tomorrow Unveiled: Your Weekly Tech Briefing · July 18 · 19 min

The Damage Was Never Permanent

For 40 years, advanced glycation damage was thought permanent. Now Revel Pharmaceuticals published peer-reviewed evidence in Nature Communications showing CMLase enzyme can reverse it. Researchers removed 70% of aging damage from 75-year-old tissue, restoring it to 31-year-old levels. Watch the full breakdown of this paradigm shift in longevity science - from irreversible to engineered repair. #ReverssingAging #LongevityScience #AntiAgingBreakthrough #RevelPharmaceuticals #CMLaseEnzyme #AgingRepair #BiotechInnovation #NatureCommunications Watch on YouTube: https://www.youtube.com/watch?v=pR9Okpb0HN8

0:00-19:13
Play in

transcript

No transcript — this publisher did not publish one.

show notes

For 40 years, advanced glycation damage was thought permanent. Now Revel Pharmaceuticals published peer-reviewed evidence in Nature Communications showing CMLase enzyme can reverse it. Researchers removed 70% of aging damage from 75-year-old tissue, restoring it to 31-year-old levels. Watch the full breakdown of this paradigm shift in longevity science - from irreversible to engineered repair. #ReverssingAging #LongevityScience #AntiAgingBreakthrough #RevelPharmaceuticals #CMLaseEnzyme #AgingRepair #BiotechInnovation #NatureCommunications

Watch on YouTube: https://www.youtube.com/watch?v=pR9Okpb0HN8

more episodes

All episodes